Robson Cavalcante Veras Selected Research

epiyangambin

5/2014

Calcium influx inhibition is involved in the hypotensive and vasorelaxant effects induced by yangambin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robson Cavalcante Veras Research Topics

Disease

3	Infections 04/2024 - 12/2015
2	Hypertension (High Blood Pressure) 07/2023 - 05/2022
2	Neoplasms (Cancer) 09/2021 - 08/2012
1	Dyspnea (Shortness of Breath) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Acute Disease 10/2021
1	Weight Gain 09/2021
1	Cardiomegaly (Heart Hypertrophy) 09/2021
1	Overweight 01/2020
1	Tachycardia (Tachyarrhythmias) 05/2014
1	Sarcoma 180 08/2012
1	Leukopenia 08/2012
1	Hemolysis 08/2012

Drug/Important Bio-Agent (IBA)

2	PerforinIBA 01/2023 - 04/2022
1	Programmed Cell Death 1 ReceptorIBA 04/2024
1	erucylphosphocholineIBA 07/2023
1	carvacrolIBA 07/2023
1	almond oilIBA 05/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2022
1	GlucansIBA 05/2022
1	Granzymes (Granzyme)IBA 04/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022
1	AntigensIBA 04/2022
1	CytokinesIBA 10/2021
1	AntioxidantsIBA 09/2021
1	LipidsIBA 09/2021
1	PolymersIBA 09/2021
1	Urea (Carbamide)FDA LinkGeneric 09/2021
1	CholesterolIBA 09/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-12 (IL 12)IBA 12/2015
1	epiyangambinIBA 05/2014
1	Trypan Blue FDA Link 08/2012
1	Fluorouracil (Carac)FDA LinkGeneric 08/2012
1	ent-7alpha-acetoxytrachyloban-18-oic acidIBA 08/2012

Therapy/Procedure

1	Immunomodulation 09/2021
1	Oral Administration 09/2021
1	Controlled Hypotension 05/2014